Bioanalytical
Smither provides comprehensive bioanalytical services supporting drug development from early discovery through clinical development and regulatory submission. Our expert scientists deliver method development, validation, and sample analysis for small molecules, biologics, and biomarkers — all performed in compliance with FDA, EMA, and ICH guidelines within our GLP- and GCP-compliant facilities.
Services
Comprehensive bioanalytical services spanning ligand binding assays, LC-MS/MS small molecule quantification, immunogenicity testing, biomarker analysis, and cell-based assay development to support all phases of drug development.
Technologies & Platforms
State-of-the-art analytical platforms including ELISA, MSD electrochemiluminescence, flow cytometry, high-resolution mass spectrometry, and automated liquid handling systems to deliver accurate, reproducible results.
Ask an Expert
Connect with our experienced bioanalytical scientists to discuss your study design, method development challenges, regulatory strategy, or any aspect of your bioanalytical program.
Scientific Resources
Access our library of white papers, application notes, webinars, and regulatory guidance documents covering bioanalytical method validation, immunogenicity assessment, and emerging analytical technologies.